We are thrilled to announce that the highly anticipated N-Nitroso impurities of Amide and Indole have now been successfully developed e.g. N-Nitroso Orlistat , N-Nitroso Ropinirole , N-Nitroso Caprolactam ,N-Nitroso Gabapentin EP Impurity A , N-Nitroso Rizatriptan , N-Nitroso Zolmitriptan, N-Nitroso Naratriptan , N-Nitroso Tadalafil , N-Nitroso Eletriptan etc. are ready Stock
search icon
We are thrilled to announce that the highly anticipated N-Nitroso impurities of Amide and Indole have now been successfully developed e.g. N-Nitroso Orlistat , N-Nitroso Ropinirole , N-Nitroso Caprolactam ,N-Nitroso Gabapentin EP Impurity A , N-Nitroso Rizatriptan , N-Nitroso Zolmitriptan, N-Nitroso Naratriptan , N-Nitroso Tadalafil , N-Nitroso Eletriptan etc. are ready Stock

Menu

Nitroso

Nitrosamines are a group of chemical compounds that contain the nitroso functional group (NO) attached to an amine group (-NH). They can form in various ways, including through industrial processes, combustion, and certain chemical reactions, particularly involving nitrites and secondary amines. Nitrosamines are of concern because Many nitrosamines (N-Nitrosamines) are potent genotoxins; some have been classified as possible human carcinogens, although the degree of risk can vary depending on factors such as the amount of exposure and individual susceptibility. Synchemia Research Chemical is dedicated to thoroughly investigating the formation of nitroso impurities in APIs, including those related to the manufacturing processes. This approach indicates a proactive stance toward quality control and regulatory compliance. By exploring all potential sources of nitroso impurities, including those arising from the production processes themselves, Synchemia Research Chemical demonstrates a commitment to ensuring the purity, safety, and efficacy of their pharmaceutical products. Nitrosoamines, including N-Des-methyl Nitroso impurities, are important in pharmaceutical research and development due to their potential impact on drug safety and efficacy. Understanding and controlling the presence of these impurities is crucial for ensuring the quality and safety of pharmaceutical products. Can N-Nitrosamines exist in two different stable forms? N-nitrosamines substituted with two different alkyl groups can exist in two different stable forms distinguishable by several analytical methods. The two rotamers may differ in their overall dipole moment and therefore may posses different chemical and physical properties. Why do I see two peaks when analyzing N-Nitrosamines by HPLC or GC? HPLC and GC)analysis of N-nitrosamines may show two rotamers of the N-nitrosamine as two separate peaks. Whether two peaks are observed depends on the structure of the N-nitrosamine (i.e., symmetric vs. asymmetric) as well as the separation power of the analytical method.
We are the Synchemia Research Chemical specializes in manufacturing and exporting various nitrosoamine compounds, particularly focusing on N-Des-methyl Nitroso impurities of various APIs and nitroso compounds of direct APIs that contain secondary amines. By specializing in the synthesis and export of these compounds, Synchemia Research likely plays a significant role in supporting the pharmaceutical industry's efforts to meet regulatory requirements and ensure the highest standards of quality and safety in drug manufacturing.
download image Download catalogue

Pharmaceutical Reference Standards

N-Nitroso Capivasertib N-oxide Impurity 2
N-Nitroso Capivasertib N-oxide Impurity 2
CAT No SRC-N0143840
CAS No NA
Mol.F. C21H24ClN7O4
Mol.Wt. 473.92 g/mole
INV STATUS CUSTOM SYNTHESIS
N-Nitroso Capivasertib N-oxide Impurity 3
N-Nitroso Capivasertib N-oxide Impurity 3
CAT No SRC-N0143841
CAS No NA
Mol.F. C21H24ClN7O4
Mol.Wt. 473.92 g/mole
INV STATUS CUSTOM SYNTHESIS
N-Nitroso Capivasertib Impurity 6
N-Nitroso Capivasertib Impurity 6
CAT No SRC-N0143842
CAS No NA
Mol.F. C26H32ClN7O5
Mol.Wt. 558.04 g/mole
INV STATUS CUSTOM SYNTHESIS
N-Nitroso Capivasertib Impurity 7
N-Nitroso Capivasertib Impurity 7
CAT No SRC-N0143843
CAS No NA
Mol.F. C26H32ClN7O5
Mol.Wt. 558.04 g/mole
INV STATUS CUSTOM SYNTHESIS
N-Nitroso Capivasertib Impurity 8
N-Nitroso Capivasertib Impurity 8
CAT No SRC-N0143844
CAS No NA
Mol.F. C20H22ClN7O2
Mol.Wt. 427.89 g/mole
INV STATUS CUSTOM SYNTHESIS
N-Nitroso Capivasertib Impurity 9
N-Nitroso Capivasertib Impurity 9
CAT No SRC-N0143845
CAS No NA
Mol.F. C21H24ClN7O2
Mol.Wt. 441.92 g/mole
INV STATUS CUSTOM SYNTHESIS
N-Nitroso Capivasertib Impurity 10
N-Nitroso Capivasertib Impurity 10
CAT No SRC-N0143846
CAS No NA
Mol.F. C22H24ClN7O2
Mol.Wt. 453.93 g/mole
INV STATUS CUSTOM SYNTHESIS
N-Nitroso Capivasertib Impurity 11
N-Nitroso Capivasertib Impurity 11
CAT No SRC-N0143847
CAS No NA
Mol.F. C21H24ClN7O2
Mol.Wt. 441.92 g/mole
INV STATUS CUSTOM SYNTHESIS
N-Nitroso Capivasertib Impurity 12
N-Nitroso Capivasertib Impurity 12
CAT No SRC-N0143848
CAS No NA
Mol.F. C21H24ClN7O2
Mol.Wt. 441.92 g/mole
INV STATUS CUSTOM SYNTHESIS
N-Nitroso Capivasertib Impurity 13
N-Nitroso Capivasertib Impurity 13
CAT No SRC-N0143849
CAS No NA
Mol.F. C20H23ClN8O2
Mol.Wt. 442.91 g/mole
INV STATUS CUSTOM SYNTHESIS
N-Nitroso Capivasertib Impurity 14
N-Nitroso Capivasertib Impurity 14
CAT No SRC-N0143850
CAS No NA
Mol.F. C22H26ClN7O3
Mol.Wt. 471.95 g/mole
INV STATUS CUSTOM SYNTHESIS
N-Nitroso Capivasertib Impurity 15
N-Nitroso Capivasertib Impurity 15
CAT No SRC-N0143851
CAS No NA
Mol.F. C22H26ClN7O3
Mol.Wt. 471.95 g/mole
INV STATUS CUSTOM SYNTHESIS
N-Nitroso Capivasertib Impurity 16
N-Nitroso Capivasertib Impurity 16
CAT No SRC-N0143852
CAS No NA
Mol.F. C20H22ClN7O3
Mol.Wt. 443.15 g/mole
INV STATUS CUSTOM SYNTHESIS
N-Nitroso Capivasertib Impurity 17
N-Nitroso Capivasertib Impurity 17
CAT No SRC-N0143853
CAS No NA
Mol.F. C23H29ClN8O2
Mol.Wt. g/mole
INV STATUS CUSTOM SYNTHESIS
N-Nitroso Capivasertib Impurity 18
N-Nitroso Capivasertib Impurity 18
CAT No SRC-N0143854
CAS No NA
Mol.F. C14H16N4O3
Mol.Wt. 288.31 g/mole
INV STATUS CUSTOM SYNTHESIS
N-Nitroso Capivasertib Impurity 20
N-Nitroso Capivasertib Impurity 20
CAT No SRC-N0143855
CAS No NA
Mol.F. C11H19N3O5
Mol.Wt. 273.29 g/mole
INV STATUS IN STOCK

Let’s advance your research together.

Partner with us for specialized chemical materials and synthesis services that enable pharmaceutical innovation.